Company news

Theravance Biopharma, Inc. news in 2019

Theravance Biopharma, Inc.'s news releases, calls and decks from 2019, newest first.

View company

Theravance Biopharma Announces Dosing of First Patient in Phase 2 Allergen Challenge Study of TD-8236, an Investigational, Lung-Selective, Inhaled Pan-Janus Kinase (JAK) Inhibitor for Inflammatory Lung Diseases

December 2, 2019

Theravance Biopharma to Present at Two Upcoming Investor Conferences

November 25, 2019

Theravance Biopharma to Present at the 2019 Credit Suisse Healthcare Conference

November 5, 2019

Theravance Biopharma, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update

November 4, 2019

Theravance Biopharma to Report Third Quarter 2019 Financial Results on November 5

October 28, 2019

Theravance Biopharma and Mylan to Present New Data on YUPELRI® (revefenacin) at the 2019 CHEST Annual Meeting

October 20, 2019

Theravance Biopharma Reports Positive Results from Phase 1 Clinical Trial of TD-8236, an Investigational, Lung-Selective, Inhaled Pan-Janus Kinase (JAK) Inhibitor for Inflammatory Lung Diseases

September 8, 2019

Theravance Biopharma, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update

July 30, 2019

Theravance Biopharma to Report Second Quarter 2019 Financial Results on July 31

July 24, 2019

Theravance Biopharma Reports New Data from Phase 2 Study of Ampreloxetine (TD-9855) in Oral Presentation at 32nd European Neurology Congress

July 21, 2019

Theravance Biopharma Reports New Data from Phase 2 Study of Ampreloxetine (TD-9855) in Presentation at 2019 International Association of Parkinsonism and Related Disorders (IAPRD) World Congress

June 17, 2019

Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories

June 13, 2019

Theravance Biopharma Appoints Andrew Hindman as Senior Vice President and Chief Financial Officer

June 3, 2019

Theravance Biopharma to Present at the 18th Annual Needham Healthcare Conference

April 1, 2019

Decks in 2019